Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
Dendritic cells (DCs) possess the specialized potential to present exogenously derived antigen to cytotoxic T lymphocytes to elicit an immune response. This process, termed cross presentation, is crucial in the generation of immune response to viruses, tumors and in autoimmune disease. The ability o...
Autors principals: | Sachamitr, P, Fairchild, P |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2012
|
Ítems similars
-
iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
per: Horton, C, et al.
Publicat: (2019) -
Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.
per: Sachamitr, P, et al.
Publicat: (2014) -
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
per: Sachamitr, P, et al.
Publicat: (2018) -
Induced pluripotent stem cells: Challenges and opportunities for cancer immunotherapy
per: Patty eSachamitr, et al.
Publicat: (2014-04-01) -
STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy
per: Nguyen Thi Nguyen, et al.
Publicat: (2024-12-01)